rilmenidine has been researched along with Obesity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Chung, HH | 1 |
| Ernsberger, P; Koletsky, RJ; Velliquette, RA | 1 |
| Jacob, R; Rupp, H | 1 |
3 other study(ies) available for rilmenidine and Obesity
| Article | Year |
|---|---|
Improvement of obesity by activation of I1-imidazoline receptors in high fat diet-fed mice.
Topics: Adipose Tissue, White; Animals; Body Weight; Diet, High-Fat; Energy Intake; Humans; Imidazoline Receptors; Male; Mice; Mice, Inbred C57BL; Obesity; Oxazoles; Rilmenidine | 2013 |
The role of I(1)-imidazoline receptors and alpha(2)-adrenergic receptors in the modulation of glucose and lipid metabolism in the SHROB model of metabolic syndrome X.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Benzofurans; Blood Pressure; Disease Models, Animal; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Imidazoles; Imidazoline Receptors; Lipid Metabolism; Male; Metabolic Syndrome; Obesity; Oxazoles; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-2; Receptors, Drug; Rilmenidine; Yohimbine | 2003 |
Excess catecholamines and the metabolic syndrome: should central imidazoline receptors be a therapeutic target?
Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; Catecholamines; Energy Intake; Energy Metabolism; Humans; Imidazoles; Imidazoline Receptors; Medulla Oblongata; Models, Biological; Neurons; Obesity; Oxazoles; Receptors, Drug; Rilmenidine; Social Conditions; Stress, Psychological; Sympathetic Nervous System | 1995 |